文献速递乳腺癌

2008—2012年中国肿瘤登记地区女性乳腺癌发病与死亡报告

[Report of breast cancer incidence and mortality in China registry regions, 2008-2012].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

国家癌症中心基于2008—2012年135个登记处数据估计中国女性乳腺癌发病与死亡。女性乳腺癌发病率为42.67/10万,世标率28.87/10万;死亡率为10.36/10万,世标率6.61/10万。城市发病与死亡均高于农村,东部高于中西部;乳腺癌居女性恶性肿瘤发病第1位、死亡第6位,城乡负担差异明显。

要点

  • 女性乳腺癌发病率为42.67/10万,城市51.85/10万高于农村28.29/10万。
  • 女性乳腺癌死亡率为10.36/10万,城市11.64/10万高于农村8.36/10万。
  • 2003—2012年中标发病率增长30.56%,农村增幅72.32%高于城市23.48%。

核心结论

  • 中国女性乳腺癌发病和死亡水平在世界范围看较低,但已居我国女性恶性肿瘤发病第1位、死亡第6位。
  • 全国乳腺癌城乡负担差异明显,今后应根据各地区情况制订相应有效的肿瘤防控策略。

研究设计与样本

  • 国家癌症中心收集全国肿瘤登记中心2008—2012年登记数据,最终纳入135个登记处,每个登记处至少包括2010—2012年数据。
  • 按地区(城乡及东、中、西部)和年龄别分层估计全国女性乳腺癌发病与死亡,中标率采用2000年中国人口普查标准人口,世标率采用Segi's标准人口。
  • 覆盖登记人口629 333 910人年,其中城市382 669 450人年、农村246 664 460人年。

主要发现

  • 2008—2012年估计全国新发女性乳腺癌13.3万例,死亡3.2万例。
  • 女性乳腺癌发病率为42.67/10万,世标率28.87/10万;城市51.85/10万高于农村28.29/10万,东部46.35/10万高于中部36.38/10万和西部27.60/10万。
  • 年龄别发病率随年龄增长而升高,55~59岁组达高峰96.36/10万,60岁后开始下降。
  • 女性乳腺癌死亡率为10.36/10万,世标率6.61/10万;城市11.64/10万高于农村8.36/10万,东部10.81/10万高于中部7.38/10万和西部9.90/10万。
  • 年龄别死亡率随年龄增长而升高,85岁以上年龄组最高61.25/10万。

关键数值与推荐

  • 2003—2012年中标发病率增长30.56%,其中农村增长72.32%高于城市23.48%。
  • 2003—2012年中标死亡率增长6.23%,增长以农村为主54.94%,城市下降2.32%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: The registration data of local cancer registries from 2008 to 2012 were collected by National Central Cancer Registry to estimate the incidence and mortality of female breast cancer in China. Methods: Data from 135 registries were qualified and selected in the final analysis, and each registry at least has submitted data from 2010 to 2012. Cancer incidence and mortality analyses were stratified by area (urban/rural, eastern/middle/western areas) and age group. The age composition of standard population of Chinese census in 2000 and Segi's population were used for age-standardized incidence and mortality in China and worldwide, respectively. Results: A total of 135 registries were recruited in the analysis, covering 629 333 910 person-years (382 669 450 in urban and 246 664 460 in rural). About 13, 258 cases of female breast cancer were diagnosed and 32 205 cases were dead between 2008 and 2012. Female breast cancer incidence was 42.67/100, 000 and age-standardized rate calculated by worldwide standard population was 28.87/100, 000. The crude incidence of urban area was 51.85/100, 000, higher than 28.29/100, 000 of rural area, and the crude incidence of eastern area was 46.35/100, 000, higher than 36.38/100, 000 of middle area and 27.60/100, 000 of western area. The age-specific incidence increased with age and reached the peak at age 55-59 (96.36/100, 000), and declined at age 60. The age-standardized incidence rate by Chinese standard population increased 30.56% from 2003 to 2012. The increase rate of rural area was 72.32%, faster than 23.48% of urban area. Female breast cancer mortality was 10.36/100, 000 and the age-standardized rate calculated by worldwide standard population was 6.61/100, 000. The crude mortality of urban area was 11.64/100, 000, higher than 8.36/100, 000 of rural area, and the crude mortality of eastern area was 10.81/100, 000, higher than 7.38/100, 000 of middle area and 9.90/100, 000 of western area. The age-specific incidence increased with age and reached the peak at age above 85 (61.25/100, 000). Age-standardized incidence rate by Chinese standard population remained stable during the period of 2003-2012 (6.23%). The mortality rate mainly increased in rural area (54.94%), while decreased 2.32% in urban area over the 10 years. Conclusions: Although the incidence and mortality of breast cancer in China are comparatively low worldwide, in China the incidence and mortality of female breast cancer have rose to the first and sixth place respectively among all the female cancers. The disease burden of breast cancer is very different between urban and rural area. Therefore, the targeted measure and strategy of control and prevention according to the area difference are needed. 目的: 分析全国肿瘤登记中心收集的全国各登记处上报的2008—2012年恶性肿瘤的登记资料,估计全国女性乳腺癌的发病和死亡情况。 方法: 全国肿瘤登记中心共纳入135个登记处上报的数据,纳入登记处至少包括2010—2012年的数据。将入选的登记处按地区(城乡以及东、中、西部)和年龄别的发病率和死亡率分层,估计全国女性乳腺癌的发病和死亡情况。中国人口标化率(中标率)采用2000年全国人口普查的标准人口年龄构成,世界人口标化率(世标率)采用Segi′s标准人口年龄构成。 结果: 2008—2012年共纳入登记处135个,覆盖登记人口629 333 910人年(其中城市382 669 450人年,农村246 664 460人年)。估计全国2008—2012年新发女性乳腺癌13.3万例,死亡3.2万例。女性乳腺癌的发病率为42.67/10万,世标率为28.87/10万;城市(51.85/10万)高于农村(28.29/10万);东部地区(46.35/10万)高于西部(27.60/10万)和中部地区(36.38/10万)。年龄别发病率随年龄的增长而升高,55~59岁组达到高峰(96.36/10万),60岁后开始下降。2003—2012年女性乳腺癌的中标发病率增长明显,2012年比2003年增长了30.56%;农村地区增长幅度(72.32%)高于城市地区(23.48%)。女性乳腺癌的死亡率为10.36/10万,世标率为6.61/10万。城市女性乳腺癌的死亡率(11.64/10万)高于农村(8.36/10万);东部地区(10.81/10万)高于西部(9.90/10万)和中部地区(7.38/10万)。年龄别死亡率随年龄的增长而升高,85岁以上年龄组最高(61.25/10万)。2003—2012年间中标死亡率变化不大,2012年比2003年增长了6.23%;增长以农村为主(54.94%),城市地区2012年比2003年下降了2.32%。 结论: 尽管从世界范围看,中国女性乳腺癌的发病和死亡水平很低,但女性乳腺癌已经成为我国女性恶性肿瘤发病第1位、死亡第6位的恶性肿瘤。全国乳腺癌城乡负担差异明显,今后应根据各地区情况制订相应有效的肿瘤防控策略。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang ML, Peng P, Wu CX, et al. [Report of breast cancer incidence and mortality in China registry regions, 2008-2012]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31014059. doi:10.3760/cma.j.issn.0253-3766.2019.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。